Skip to main content
eScholarship
Open Access Publications from the University of California

Continuous TRANSVERSUS ABDOMINIS PLANE (TAP) blocks for postoperative pain control after hernia surgery: A randomized, triple-masked, placebo-controlled study

  • Author(s): Heil, JW
  • Nakanote, KA
  • Madison, SJ
  • Loland, VJ
  • Mariano, ER
  • Sandhu, NS
  • Bishop, ML
  • Agarwal, RR
  • Proudfoot, JA
  • Ferguson, EJ
  • Morgan, AC
  • Ilfeld, BM
  • et al.

Published Web Location

https://doi.org/10.1111/pme.12530
Abstract

© 2014 American Academy of Pain Medicine 15 11 November 2014 10.1111/pme.12530 ACUTE PAIN & PERIOPERATIVE PAIN SECTION Original Research Article Original Research Article Wiley Periodicals, Inc. Background: Single-injection transversus abdominis plane (TAP) block provides postoperative analgesia and decreases supplemental analgesic requirements. However, there is currently no evidence from randomized, controlled studies investigating the possible benefits of continuous TAP blocks. Therefore, the aim of this randomized, triple-masked, placebo-controlled study was to determine if benefits are afforded by adding a multiple-day, ambulatory, continuous ropivacaine TAP block to a single-injection block following hernia surgery. Methods: Preoperatively, subjects undergoing unilateral inguinal (N=19) or peri-umbilical (N=1) hernia surgery received unilateral or bilateral TAP perineural catheter(s), respectively. All received a ropivacaine 0.5% (20mL) bolus via the catheter(s). Subjects were randomized to either postoperative perineural ropivacaine 0.2% or normal saline using portable infusion pump(s). Subjects were discharged home where the catheter(s) were removed the evening of postoperative day (POD) 2. Subjects were contacted on POD 0-3. The primary endpoint was average pain with movement (scale: 0-10) queried on POD 1. Results: Twenty subjects of a target 30 were enrolled due to the primary surgeon's unanticipated departure from the institution. Average pain queried on POD 1 for subjects receiving ropivacaine (N=10) was a mean (standard deviation) of 3.0 (2.6) vs 2.8 (2.7) for subjects receiving saline (N=10; 95% confidence interval difference in means -2.9 to 3.4; P=0.86). There were no statistically significant differences detected between treatment groups in any secondary endpoint. Conclusions: The results of this study do not support adding an ambulatory, continuous ropivacaine infusion to a single-injection ropivacaine TAP block for hernia surgery. However, the present investigation was underpowered, and further study is warranted.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Main Content
Current View